Oxis own several patents and pending applications related to ERGO that cover current and planned products relevant to their nutraceutical and cosmecuetical businesses. Their patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process. Oxis products include therapeutic nutraceutical products, cosmeceutical products and proprietary formulations and clinical products that are developed internally and/or out-licensed to biotech and pharmaceutical companies as drug candidates.
Oxis is developing and plans to sell Nutraceutical and Cosmecuetical products featuring natural ingredients believed to have beneficial effects on human health. Oxis’ first products will include L-Ergothioneine (ERGO) as a key component. ERGO is a very powerful, multifaceted antioxidant such as Vitamin E, Vitamin C and glutathione.
Other products are being evaluated and include a line of skin care products. In addition they will develop other nutraceuticals and functional foods such as nutrition bars, energy beverages and single serve shots that lend themselves to traditional retail distribution. Oxis International, Inc. is a great investment for your future. Currently Oxis International is listed as a penny stock.
You can follow Oxis on Twitter for update information. And also find Oxis on facebook to share with them.